Clinical Trial Update: Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients (ANRS119) [Phase 2]

View source ↗

Summary

Phase 2 trial ANRS119 evaluated interleukin-2 for efficacy in antiretroviral-naïve HIV patients; the study has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: HIV Infections | Phase 2 | Status: COMPLETED